Log in to save to my catalogue

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotrans...

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotrans...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1edc1446dc3a4fa1b38b52c97c3a7f14

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions

About this item

Full title

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions

Publisher

Switzerland: Frontiers Research Foundation

Journal title

Frontiers in behavioral neuroscience, 2015-03, Vol.9, p.78-78

Language

English

Formats

Publication information

Publisher

Switzerland: Frontiers Research Foundation

More information

Scope and Contents

Contents

Autoantibodies to the smaller isoform of glutamate decarboxylase (GAD) can be found in patients with type 1 diabetes and a number of neurological disorders, including stiff-person syndrome, cerebellar ataxia and limbic encephalitis. The detection of disease-specific autoantibody epitopes led to the hypothesis that distinct GAD autoantibodies may el...

Alternative Titles

Full title

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1edc1446dc3a4fa1b38b52c97c3a7f14

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1edc1446dc3a4fa1b38b52c97c3a7f14

Other Identifiers

ISSN

1662-5153

E-ISSN

1662-5153

DOI

10.3389/fnbeh.2015.00078

How to access this item